c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
argenx (ARGX) to Present Positive Phase 3 ALKIVIA Trial Data on VYVGART Hytrulo at ACR 2026
GuruFocus | Nov 8, 2026 1:25 PM EST
Related Stocks: ARGX ,
Read original article